Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis

Biophys Chem. 2022 Feb:281:106736. doi: 10.1016/j.bpc.2021.106736. Epub 2021 Dec 6.

Abstract

Cytoplasmic deposition of aberrantly misfolded α-synuclein (α-Syn) is a common feature of synucleinopathies, including Parkinson's disease (PD). However, the precise pathogenic mechanism of α-Syn in synucleinopathies remains elusive. Emerging evidence has suggested that α-Syn may contribute to PD pathogenesis in several ways; wherein the contribution of fibrillar species, for exerting toxicity and disease transmission, cannot be neglected. Further, the oligomeric species could be the most plausible neurotoxic species causing neuronal cell death. However, understanding the structural and molecular insights of these oligomers are very challenging due to the heterogeneity and transient nature of the species. In this review, we discuss the recent advancements in understanding the formation and role of α-Syn oligomers in PD pathogenesis. We also summarize the different types of α-Syn oligomeric species and potential mechanisms to exert neurotoxicity. Finally, we address the possible ways to target α-Syn as a promising approach against PD and the possible future directions.

Keywords: Amyloid; LLPS; Neurotoxicity; Oligomers; α-Synuclein.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Humans
  • Parkinson Disease* / metabolism
  • Synucleinopathies*
  • alpha-Synuclein / chemistry

Substances

  • alpha-Synuclein